According to DelveInsight’s analysis, the growth of the KRAS Inhibitors market is expected to be mainly driven by increasing incidence, a rise in awareness and access to treatment, and robust pipeline ...

As China continuous to develop, its biomedical industry is undergoing an important phase. Strategic opportunities are ...

In this article, we will be taking a look at the 7 best dialysis and kidney disease stocks to buy. Global Kidney Treatment ...

UBS initiated 'sell' calls on Dr Reddy's Laboratories Lupin, Aurobindo Pharma and Zydus Lifesciences while picking Sun Pharma ...

Drug discovery informatics continues to revolutionize the field of drug discovery by leveraging cutting-edge technologies and methodologies. One ...

Altium Capital is known for its strategic investments in biotechnology and pharmaceutical companies, aiming to capitalize on ...

The guidance is based in part on responses the agency received to a 2023 discussion paper on the topic. The paper received ...

Researchers have developed MED6-189, a new drug effective against drug-sensitive and drug-resistant strains of human malaria ...

In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and ...

Piper Sandler analysts have published their monthly highest-conviction stock list. Six stocks are featured this month, ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore, is partnering with ...

Prior to the COVID-19 pandemic, the activities of medical and pharmaceutical laboratories seldom received national or ...